Want to join the conversation?
Specialty biopharmaceutical company $SHPG said it is buying $BXLT. Under the agreement terms, $BXLT shareholders will receive $18 in cash and 0.1482 Shire ADS per Baxalta share. Based on $SHPG's closing ADS price on Jan. 8, 2016, this entails a total current value of $45.57 per $BXLT share, representing an aggregate consideration of approx. $32Bil.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.